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Over the past 25 years, the concept that perinatal events influence an individual’s later health and susceptibility 
to disease has gained traction. After original observations by 
Barker et al,1 epidemiological studies have identified a link 
between markers such as lower birth weight and placental 
weight with later cardiovascular, metabolic, and other diseases. 
The theory of fetal programming in response to the intrauterine 
environment has been supported by a body of elegant experi-
mental investigations in animals. However, findings from clini-
cal investigations in humans have not always been consistent, 
and other factors such as weight gain trajectories and various 
environmental exposures, such as diet, stress, and lifestyle 
behaviors, also influence later health. Moreover, prospective 
studies in humans that begin in the neonatal or even perinatal 
period are limited. Ethical limitations in the conduct of clinical 
research in newborn infants and young children are obvious, 
and creative approaches are needed to prospectively investi-
gate the birth weight hypothesis. In this issue of Hypertension, 
Lurbe et al2 report on a study that provides new insights on 
childhood origins of chronic disease.
The authors enrolled a sample of healthy newborn infants. 
All enrolled infants were born at term after uncomplicated 
pregnancies. The investigators stratified infants according to 
birth weight (small [SGA], appropriate [AGA], or large for 
gestational age [LGA]). Blood pressure (BP) was measured at 
2 days of age. The infants were then re-examined at 6 months, 
2 years, and 5 years. At each study visit, BP and growth 
parameters were obtained. At age 5 years, a blood sample was 
obtained for measurement of metabolic parameters.
Despite the relatively small sample size (n=139) of the 
study, the results are very interesting. At birth, birth weight 
and BP are positively related. Each birth weight group gained 
similar amount of weight in each examination interval; the 
SGA infants remained the smallest and the LGA infants 
remained the largest at each subsequent examination. Weight 
gain within the first 6 months of life was similar in each birth 
weight group and was not related to BP or subsequent met-
abolic parameters. After 6 months, both current weight and 
weight gain were significantly and positively associated with 
birth weight; birth weight was not significantly associated with 
the BP level. Most interesting were the metabolic findings. As 
depicted by the authors in Figure 1, fasting insulin levels are 
higher in SGA infants who became heavy at age 5 years com-
pared with AGA and LGA infants who become heavy at age 
5 years. Most striking are the homeostatic model assessment 
index estimates of insulin resistance. As shown in the figure, 
SGA infants are insulin-resistant relative to AGA and LGA 
infants, regardless of their weight status at age 5 years. These 
findings, in a sample of healthy infants, indicate that one or 
a combination of factors related to lower birth weight set the 
stage for relative insulin resistance that is enduring and seems 
not to be driven only by excess weight gain.
Earlier epidemiological studies reported a significant inverse 
relationship between birth weight and subsequent BP, with 
hypertension considered to be a major mediating link between 
low birth weight and subsequent cardiovascular disease. Data 
in the current report by Lurbe et al2 suggest that metabolic 
variation may be a seminal mediating link as well. Regardless 
of weight gain, by age 5 years the SGA group was insulin-
resistant with lower high-density  lipoprotein-cholesterol and 
higher uric acid levels, compared with the other birth weight 
groups. Together, these relative metabolic differences suggest 
that features of the metabolic syndrome are present early, with 
the risk that high BP could possibly evolve as a consequence 
of later adiposity.
Based on epidemiological associations between greater 
body weight at 1 year of age and lower risk of later cardio-
vascular disease,3 nutritional augmentation to promote growth 
was considered beneficial for SGA infants. Subsequent stud-
ies to test this idea reported that overnutrition in early infancy 
was associated with later metabolic abnormalities4,5 and sug-
gested that overnutrition with accelerated weight gain in the 
first months of life contributed to adverse metabolic changes. 
However, metabolic assessments in these studies were 
obtained in later childhood4 or adolescence.5 Contrary to these 
reports, Lurbe et al2 found that weight gain within the first 6 
months had no effect on metabolic variations measured at age 
5 years in SGA infants. Based on a systematic review of pub-
lished evidence on the association of birth weight with type 
2 diabetes mellitus in adults, Whincup et al6 reported that in 
most populations birth weight was inversely related to type 2 
diabetes mellitus. The report by Lurbe et al2 in this issue adds 
novel findings on the low birth weight pathway to chronic dis-
ease with data demonstrating relative insulin resistance at age 
5 years in SGA infants. Recently, in a cross-sectional study 
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in Brazil, Crispim et al7 reported findings similar to those of 
Lurbe et al,2 but their study was not prospective.
Other issues of interest in the authors’ study cohort include 
the rather high rates of obesity at age 5 years. Fifty percent of 
LGA newborns were obese at age 5 years, although this sample 
was limited to 20 children. The obesity prevalence may reflect 
the current childhood obesity epidemic but could also augment 
some of the metabolic parameters that were studied. Absent are 
data on maternal and perinatal parameters including maternal 
weight, diet, social economic status, and other exposures, as 
well as maternal weight postpartum. Such information would 
permit multivariable analysis that might help control for addi-
tional factors that may have influenced the results.
In all, the results of the study by Lurbe et al2 suggest that 
metabolic status in 5-year-old children born at term may be 
influenced or programmed by perinatal events. A variety of 
potential mechanisms have been considered to explain the 
developmental origins of health and disease, such as changes 
in the microarchitecture of various organs, changes in trans-
porters or hormonal levels, and changes that involve epigene-
tic alterations. Epigenetic modification is a term that indicates 
modifications in DNA without changes in the DNA sequence 
per se. These changes may occur via methylation of cytosine 
in CpG dinucleotides, by phosphorylation, and ADP ribosyl-
ation. Other possible changes include the ubiquitination of 
histones and acetylation. Additionally, the function and con-
formation of chromatin can be altered by noncoding RNAs. 
Epigenetic modification may alter the way by which transcrip-
tion activators and repressors bind to the DNA. The type of 
epigenetic change may influence the effects—although his-
tone modifications of DNA have relatively short-term effects, 
DNA methylation may lead to longer-term changes.
There are evolving theories as to how epigenetic changes 
might influence programming of cardiovascular disease. 
Although epigenetic changes may be reversible, some epigen-
etic modifications may be inherited. In other words, epigenetic 
changes occur as part of the life cycle, but they also occur in 
response to stress. Thus, the concept that a stressful perinatal 
environment would potentially lead to epigenetic alterations 
in the stressed fetus or newborn is attractive. Some of these 
potential changes will affect the individual in later life, and 
some might be passed on to future generations. Most epigen-
etic data with respect to perinatal programming are experimen-
tal,8 but some human data support the concept that intrauterine 
stress leads to epigenetic change. For example, changes in the 
patterns of DNA methylation of insulin-like growth factor 2 
(IGF2DMR) have been noted in persons exposed to famine 
conditions in utero.9 Indeed, the IGF2 and H19 loci have been 
thought to influence birth weight and growth, though results 
are conflicting.10 Bouwland-Both et al11 recently examined a 
prospective birth cohort of SGA children in The Netherlands 
and compared them to children who were AGA at term. The 
authors extracted DNA from umbilical cord white blood cells, 
examined DNA methylation, and observed that decreased DNA 
methylation of IGF2DMR was present among SGA children.
Further epigenetic studies may be helpful to our interpreta-
tion of prospective studies such as Lurbe et al’s.2 One hopes 
that banking of cord blood samples may allow comparisons of 
physiological results to both genetic and epigenetic studies. 
To understand the phenomenon of perinatal programming, it 
will be necessary to take careful phenotypic observations such 
as those of the current study and pair them with molecular 
mechanisms. The molecular ability to do so is increasingly 
available and has the potential to deepen our understanding 
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